JP Morgan Chase
BNTC icon

JP Morgan Chase’s Benitec Biopharma BNTC Stock Holding History

JP Morgan Chase’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$114K Buy
8,996
+1,111
+14% +$13.2K ﹤0.01% 5947
2026
Q1 		$79.3K Buy
7,885
+1,857
+31% +$21.5K ﹤0.01% 5957
2025
Q4 		$81.2K Buy
6,028
+39
+0.7% +$539 ﹤0.01% 5993
2025
Q3 		$84K Sell
5,989
-849
-12% -$10.8K ﹤0.01% 6000
2025
Q2 		$80K Buy
+6,838
New +$95.7K ﹤0.01% 5707
2021
Q1 		– Sell
-4
Closed – – 6071
2020
Q4 		$0 Hold
4
– – ﹤0.01% 5639
2020
Q3 		$0 Hold
4
– – ﹤0.01% 5482
2020
Q2 		$1K Hold
4
– – ﹤0.01% 5287
2020
Q1 		$0 Buy
+4
New +$468 ﹤0.01% 5311

Other funds holding BNTC

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

JP Morgan Chase's BNTC Position: Q2 2026 in Review

JP Morgan Chase increased its Benitec Biopharma (BNTC) stake by 14% in Q2 2026, buying an estimated $13.2K and bringing the position to 8,996 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #5947.

JP Morgan Chase first reported a position in BNTC in Q1 2020 and has held it in 9 quarters since. 87 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • JP Morgan Chase held 8,996 shares of Benitec Biopharma worth $114K as of Q2 2026.
  • JP Morgan Chase bought 1,111 Benitec Biopharma shares in Q2 2026, an estimated $13.2K.
  • Benitec Biopharma made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5947 holding.
  • JP Morgan Chase first reported a position in Benitec Biopharma in Q1 2020 and has held it in 9 quarters since.
  • 87 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.